title: Letter by Abdellaoui et al regarding article, "Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention".
authors.forename: Mohamed
authors.initials: M
authors.lastname: Abdellaoui
authors.forename: Gilles
authors.initials: G
authors.lastname: Rioufol
authors.forename: Gérard
authors.initials: G
authors.lastname: Finet
mesh_terms: D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003331:Coronary Vessels / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab